4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-25-000014
Chief Financial Officer gave up 4,929 shares (to pay taxes)
- Chief Financial Officer acquired 42,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
WENTWORTH KORY JAMES · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-01 | Grant or award : show line 1 in the form | +42,400 | 116,249 | D | ||
| 2025-03-03 | Shares withheld for taxes : show line 2 in the form | −4,929 | $11.68 | $57,564 | 111,320 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-01 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +63,300 | 63,300 | D |
Loading xslF345X05/wk-form4_1741125633.xml…